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       Abstract—Transitional (TR) B cells are immature B cells that 
have migrated from the bone marrow to peripheral lymphoid 
organs, but can still undergo selection against autoreactivity.  TR 
cells that survive selection eventually develop into mature naïve B 
cells (CD27-IgD+, NA). Upon exposure to antigen, NA cells may 
become IgM memory (CD27+IgD+, MM) or "classical", class-
switched memory (CD27+IgD-, SM) B cells. Although MM 
immunoglobulin (Ig) genes do not undergo class switching, they 
do undergo somatic hypermutation, albeit with lower frequency 
than SM. It has been postulated that MM B cells originate from 
T-independent immune responses, while SM cells originate from 
T-dependent responses. Alternatively, MM cells may be early 
emigrants from T-dependent germinal centers. Double negative B 
cells (CD27-IgD-, DN) have been said to be exhausted memory 
cells, but their precise origin is unclear. Therefore, a definitive 
elucidation of lineage relationships between these different B cell 
subsets is needed.  
In this study, we used lineage tree analysis of Ig heavy chain gene 
sequences from five human B cell subsets (TR, NA, MM, SM and 
DN) from three individuals, to study the relationships between 
these B cell populations and garner insights regarding their roles 
in immune responses. Our analyses confirmed that both MM and 
SM branches can include DN Ig sequences, sometimes identical to 
SM Ig sequences. MM trees were significantly shorter than SM 
trees. Even when they belonged to the same clone, MM branches 
were shorter, consistent with either an early exit of MM cells 
from germinal centers in a T-dependent response, before 
accumulating many mutations, or their generation by T-
independent responses. Our finding of combined trees that 
included both MM and SM sequences suggests that at least some 
MM cells originate from the same clones as SM, rather than 
develop separately. 
 
Keywords—memory B cells; immunoglobulin; high-throughput 
sequencing; somatic hypermutation 
I.  INTRODUCTION  
During B cell development, haematopoietic stem cells in the 
bone marrow (BM) undergo several stages of differentiation 
into immature B cells [1] that later  enter the peripheral 
compartment [2]. In the developmentally intermediate stage 
between immature BM B lineage cells and fully mature naive 
B cells in the peripheral blood (PB) and secondary lymphoid 
tissues, the B cells are called ‘transitional (TR) B cells’ (Fig 
1). These cells in humans are deﬁned as CD27–IgD+CD10+ 
and constitute less than 1% of B cells [3]. After the TR B cells 
leave the BM, they can undergo further selection against 
autoreactivity [4]–[6] and the remaining small fraction 
develops eventually into mature naïve B cells (NA, CD27–
IgD+, Fig 1) [7]–[9]. This maturation is associated with the co-
expression of IgM and IgD [10]; about 50% of all B cells in 
human peripheral blood are naïve [3]. Naïve B cells with 
mature phenotypic characteristics and a fully functional BCR 
recirculate between the secondary lymphoid tissues, dying 
after a few days. 
Upon exposure to antigen the NA cells become IgM memory 
(MM, CD27+IgD+, Fig 1), which constitute about 14% of the 
B cells [3], or "classical", class-switched memory cells (SM, 
CD27+IgD–, Fig 1) which constitute about 7% [3]. Both MM 
and SM undergo SHM in their Ig variable region genes and 
show characteristics of antigen selection [11]–[13]. However, 
IgA and IgG SM, which are derived from T cell-dependent 
responses in the GC, have highly somatically hypermutated Ig 
genes [14]–[16]. The expression of CD27 correlates with 
greater cell size [14],[15], proliferative capacity [19]–[22], 
antigen presentation capacity [22], and differentiation into 
antibody secreting cells [20]. MM Ig genes also undergo 
SHM, though with a lower frequency then SM, but not class 
switch recombination, and have been shown to be important in 
polysaccharide responses [23],[24]. Therefore, it is assumed 
that MM cells mostly function in T-independent immune 
responses while SM cells function in T-dependent responses 
[25][26]. Alternatively, MM cells may be early immigrants 
from the T-dependent response in the GC [27] or part of the 
constitutive production of natural antibodies [28].   
It has been said that double negative B cells (DN, CD27–IgD–, 
Fig 1). [29][30] are exhausted memory cells [31],[32] which 
proliferate less than MM or SM [33]. The DN cells, like SM, 
can be stimulated to secrete Igs against tetanus toxin and 
influenza virus [17], suggesting they were involved in prior 
vaccine responses. However, it is unclear which of the 
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 Fig. 1. The transitions between B cell subsets. Transitional (TR) B cells 
become mature naïve (NA, CD27–IgD+) cells that, upon activation, become 
either IgM memory (MM, CD27+IgD+) or "classical", class-switched 
memory cells (SM, CD27+IgD–). Solid – a known transition. Dashed – a 
possible transition. 
 
memory populations, MM, SM or both, becomes DN (Fig. 1). 
Another option is that they originate via an altogether different 
maturation pathway [22]. 
The intraclonal variation achieved by SHM enables the 
construction and analysis of clonal lineage trees (also referred 
to as dendrograms or pedigrees). In a GC, there are usually 
several different B cell clones. Clonally related cells are 
identified by the use of the same V (D) and J segments and 
highly homologous sequences of the complementary 
determining region 3 (CDR3) of their Ig variable region (V) 
genes. Lineage trees depict the relationships between 
sequences in a clone, by representing each single mutation  by 
a tree node [34]. 
We developed a method of mathematically analyzing lineage 
trees by measuring their graphical properties [35]. Previous 
studies demonstrated the usefulness of this method and 
resulted in new insights regarding differences in GC dynamics 
in aging or between different tissues [35]–[37],in  autoimmune 
diseases [38], chronic inflammation [39], lymphomas [40], 
and chronic gastritis and gastric lymphomas [41]. This method 
was also used to determine clonal relationships of Ig genes 
from different tissues [39][42].  
In this study, we used Ig gene sequences from five B cell 
subsets (Transitional – TR, Naïve – NA, IgM memory – MM, 
class-switched memory cells – SM and Double negative – DN) 
from three individuals [43] to study the relationships between 
these populations as they are revealed by lineage trees. 
II. METHODS 
A. Sources of data for analysis  
All sequences were taken from Wu et a l.[43] The dataset 
includes Ig sequences from peripheral blood of three young 
healthy volunteers (21 to 26 years) that were sequenced on a 
454 GS FLX Titanium Sequencer.  
B. Data processing  
Sequence data were processed as described [41] [44]. Briefly, 
an in-house program deletes duplicate sequences (which might 
be a product of PCR amplification), and leaves only the 
unique sequences for the analysis. For each acceptable 
sequence, the V, D and J germline segments were identified 
using SoDA [45]. Groups of sequences having the same V(D)J 
segments were aligned by ClustalW [46] to identify groups of 
clonally related sequences (having the same junction regions). 
Characteristic deep sequencing errors, such as 
insertions/deletions near homopolymer tracts of three or more 
nucleotides, were also identified when possible by our in-
house program Ig-Indel-Identifier [44] and, unless another 
sequence with the same mutation was found in the clone, the 
sequence with the suspected mutation was also discarded. 
Single -sequence clones with suspected insertions/deletions 
near homopolymer tracts were discarded as well, since the 
credibility of the mutation could not be confirmed. The 
numbers of sequences remaining after each cleaning step are 
provided in Table 1. 
C. Lineage tree analysis 
Clonal groups of Ig gene sequences were transformed into 
mutational lineage trees using our program IgTree© [34], 
implementing a distance method-based algorithm that finds 
the most likely tree with a high probability. All trees were 
measured using our program MTree©[36][35], quantifying 
shape properties of the trees, such as the number of leaves, 
number of nodes, etc. According to this method, defined 
distances between key tree nodes (root, split nodes or ‘forks’ 
and leaves) reflect dynamical features of clonal evolution 
 
Table 1. The numbers of sequences in the dataset, in three individuals (A-C), at 
all stages of data cleaning from raw data to the clean, analyzed data [43].The 
number of clones of all subsets is smaller than the summary of the subsets of 
each patients because some of the clones are combined. 
 
including the mutation rate, the affinity between the target 
antigen and the B cell receptor of the Ig clone and antigen-
driven selection pressure [47]. The measurements were then 
compared between the subsets using the non-parametric 
Mann-Whitney U-test, as normal distributions (required by 
tests such as Student's T-test) could not be assumed. 
D. Mutation targeting motif analysis 
Mutation targeting motif analysis was based on previous 
work by Dunn-Walters et al. [48][49]. Briefly, the base 
composition at positions flanking a mutation (ten nucleotides 
on either side) was determined. For each nucleotide in each 
position and each type of mutation, a χ2 analysis was 
performed to check whether the frequency of the nucleotide is 
significantly different from its germline frequency. Then, the 
results for different B cell subsets were compared using the F-
test. 
III. RESULTS 
A. Data preparation and lineage tree generation 
Ig sequences of TR, NA, MM, MS and DN B cell subsets 
from PB of three young, healthy donors (Table 1)[43] were 
used to generate lineage trees. The generated trees were 
divided into two groups; combined lineage trees that include 
clonally related Ig sequences from between two and five 
subsets (mixed trees, Fig. 2) and lineage trees that contained 
sequences  from only one subset (unmixed trees).  
B. DN Lineage trees are almost as long as switched memory 
lineage trees 
In order to compare the characteristics of the individual 
subsets we only used the unmixed lineage trees. The tree 
measurements of each subset separately (Fig. 3a-c), together 
with the average number of mutations per sequence (Fig. 3 d), 
show that the TR and NA subsets had significantly fewer 
mutations, as expected. The few mutations found in TR and 
NA B cells could be differences between the person’s allele 
and the IMGT alleles, PCR errors or sequencing errors that 
were not identified by our filtering criteria.  
The MM subset had more mutations per sequence and 
significantly longer trees (more affinity maturation) than TR 
and NA, but fewer mutations and slightly shorter trees than 
DN and SM, supporting either a separate MM etiology such as 
the TI pathway, or their origin as early immigrants from the 
GC. The average number of mutations in DN was higher than 
in SM in two of the donors, in contrast to reported results 
[29][30], but DN trees had slightly fewer nodes and shorter 
trunks and PLmin (Fig.3 a-c). Since the CI is small, the origin 
of the DN cell could be either from MM cells that have 
undergone more SHM or from DN cells that retired early from 
the GC, as discussed below.  
C. Combined lineage tree analysis: DN are most likely 
related to SM cells  
To achieve a better understanding of the relationships between 
the different subsets, we studied the combined trees that 
incorporate clonally related Ig sequences from two or more 
different subsets. Examining these trees revealed several 
insights, as follows. First, three lineage trees in one of the 
patients included both MM and SM cells, confirming that 
those two subsets can develop from the same lineage; 
however, such cases are rare (Fig. 4). 
Second, some of the combined trees included SM and/or MM 
along with DN (Figures 2 and 4), confirming that the source of 
DN cells may be MM, SM or both. However, since the 
analyzed sequences represent a sample of the whole human 
repertoire, resulting in relatively small trees, sampling 
limitations precluded us from finding the exact temporal 
relationships between the different subsets. For example, MM 
cells can first become SM and then DN, but we would not 
 
Fig. 2. Examples of combined lineage trees. The numbers in the nodes 
indicate the number of sequences; the numbers on the edges indicate th  
number of mutations (Single mutations are not indicated). IgM-white, IgG-
light gray, IgA-dark gray 
 
 
Fig. 3. CI plots of lineage tree measurements; number of nodes (a), trunk size 
(b) and PL-min (c). The plots present the clones from all donors; the results of 
each of the donors were similar. (d) The average number of mutations per 
sequence in each of the subsets in donors A-C.  P values for all comparisons 
are given in supplemental Table 1, and lines in (a-c) represent significant 
differences. were found in trunk length (T) and minimal path length (PLmin). 
A line represents p-value <0.005. 
 
 
Fig. 4. A combined tree that includes SM, MM and DN cells with a DN 
sequence that is identical to SM sequences. 
know this if the SM cells were not sampled. Out of 15 lineage 
trees that included DN along with SM or MM (or both), four 
trees included identical DN and SM Ig sequences (example in 
Figures 2 and 4), while none of the trees included identical 
DN and MM Ig sequences. This may indicate that SM cells 
can directly become DN, while such an indication for MM 
cells is lacking. 
Third, in all the 15 "mixed" lineage trees, each DN sequence 
shares the isotype with the branch it belongs to (data not 
shown).  This is consistent with the hypothesis that DN B cells 
are exhausted cells that do not change further. In summary, 
lineage trees that include both MM and SM are rare, and while 
DN cells appear in lineage trees with MM and SM cells, they 
only share identical sequences with SM. 
D. Mutation characteristics are the same in all memory 
subsets 
Finally, we looked for evidence for differences in the 
mutational mechanisms in sequences from different subsets. 
We assume that a change in the mutational mechanism will be 
reflected by a change in the mutational motifs. The average 
numbers of differences in the motifs (Fig. 5, Table 2) show 
that NA and TR cells have similar mutational motifs and SM, 
DN and MM cells also have similar motifs, however the 
motifs are different between these two groups of 
subpopulations. Since the “mutations” in NA and TR cells are 
not generated by SHM and are artifacts of the method, this 
difference was expected and confirms that our methods can 
distinguish between SHM and random errors, at least 
statistically. However, this analysis could not distinguish 
between MM, SM and DN cells, showing that the SHM 
mechanism does not change between them. 
 
IV.  DISCUSSION 
In this study, we used lineage tree analysis of Ig heavy chain 
gene sequences from five human B cell subsets (TR, NA, 
MM, SM and DN) from three individuals, to study the 
relationships between the populations and garner insights 
regarding their roles in immune responses. Our analyses 
confirmed that both MM and SM branches can include DN 
cell Ig sequences, and that SM had in some of the cases 
identical Ig heavy chains to those of DN cells the DN. In 
addition, rarely, MM and SM cells can share a lineage tree. 
The similarity of the motifs in MM, SM and DN suggests that 
the source of the mutations in DN is the same as in MM and 
SM, which is SHM, rejecting the assumption that they 
originate in a completely deferent maturation pathway. Taken 
together, these results support all the suggested DN origins. 
The small CI in the tree measurements of DN cells, however, 
suggests that that these trees are not a mixture of small trees 
that originated from MM cells and large trees that originated 
from SM cells, but a uniform group of trees. The differences 
in tree lengths (total number of mutations) imply that, had 
these trees originated from the smaller MM trees, the DN cells 
would have needed to accumulate more mutations afterwards. 
Alternatively, had they originated from SM cells, the DN cells 
would have had to leave the GC before some of the SM.     
We have also seen that MM trees are significantly shorter than 
SM trees, consistent with either MM cells leaving the GC 
early, before accumulating many mutations, or their belonging 
to a separate pathway. Since combined lineage trees with both 
MM and SM cells were rare, it is more likely that MM cells 
belong to a separate pathway such as the TI response. 
However, at least some of the MM may originate from the 
same clones as SM, and therefore may be part of the classical 
TD response. 
Although, it was shown that TI stimulus in mice sends cells to 
GC and mutations occurs [50], changes in the SHM 
 
Figure 5: The average numbers of differences in sequence motifs around 
mutations. The distribution of nucleotides in each of the 10 positions up- and 
down- stream of each mutation was calculated per each mutation type and 
compared between the subsets by F-test. Then, the number of significant 
differences (P value <0.05) in each position (out of 12 options, as each 
nucleotide can be mutated to the other three) was calculated. The dotted line 
is the median, to split the high- from low- difference groups. The numbers of 
mutations included in this analysis are summarized in Table 2. 
 
 
Table 2: Numbers of mutations in each patient, in each subset and from each 
nucleotide (A,C,G and T). 
mechanism, and therefore in the motifs around the mutations, 
may be affected by the microenvironment and activating 
signals, which are likely different between TI versus TD 
response pathways. However, our motif analysis method has 
never been used to study the differences in motifs around 
SHM in B cells from TD and TI pathways, thus it remains to 
be seen whether these pathways are characterized by different 
mutational motifs. Even though we did not find differences in 
SHM motifs between MM, SM and DN, the fact that our 
method could distinguish between SHM and artifacts 
according to the mutational motifs confirms that this method 
can be applied to detect alterations from normal SHM.  
Our study did not completely resolve the questions 
regarding the origin and function of the subsets, but we have 
shown that differentiation from MM and SM to DN is likely, 
while that between MM and SM is rare. The potential size of 
the human repertoire is estimated to be 1011 unique BCR 
sequences [51], therefore a larger sample size is required in 
order to achieve the full picture of the relationships between all 
B cell populations and determine the correct model. In the 
future, when larger data sets are available, a comparison of DN 
IgM repertoire to those of MM and DN IgG/A and of SM will 
help clarify the inter-subset relationships.  
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